Literature DB >> 7609779

Moderate hypoxia reduces pentylenetetrazol-induced seizures.

C Rauca1, H L Rüthrich.   

Abstract

Mice were exposed to an atmosphere consisting of 7% O2 and 93% N2 or 5.5% O2 and 94.5% N2 for 60 min. The susceptibility of the mice to the convulsive effect of pentylenetetrazol (PTZ) was decreased, in comparison to that of naive or sham-exposed controls, 1 and 7 days after exposure to 7% O2. A significant protective effect against PTZ-induced seizures was not observed in mice exposed to 5.5% O2. N-methyl-D-aspartate (NMDA) administrated immediately after exposure to the hypoxic atmosphere, had no significant influence on the protective effect of hypoxia. Treatment of naive or sham-exposed mice with NMDA resulted in protection against PTZ-induced seizures when they were tested 7 days later. Dizolcipine (MK 801), at a dose of 0.01 mg/kg injected i.p. 10 min before hypoxia, abolished the protective effect of hypoxia; higher doses (0.1 or 0.3 mg/kg) of MK 801 were not effective. The adenosine A1 receptor antagonist 1,3-diethyl-8-phenylxanthine (DPX), administered at a dose of 0.1 mg/kg s.c. before hypoxia, blocked the decrease in the susceptibility to the convulsive effect of PTZ. DPX also blocked the protective effect, seen after 7 days, of NMDA given to control mice. These results suggest that both NMDA and adenosine A1 receptor-mediated processes were involved in the protective effect of moderate hypoxia against PTZ-evoked seizure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609779     DOI: 10.1007/BF00233245

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  48 in total

1.  Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.

Authors:  M Hiramatsu; A K Cho; T Nabeshima
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

2.  Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.

Authors:  M Y Globus; R Busto; W D Dietrich; E Martinez; I Valdes; M D Ginsberg
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

3.  Modulation of neuronal excitability by endogenous adenosine in the absence of synaptic transmission.

Authors:  J C Fowler
Journal:  Brain Res       Date:  1988-11-01       Impact factor: 3.252

4.  Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia.

Authors:  P Andiné; K A Rudolphi; B B Fredholm; H Hagberg
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model.

Authors:  R H Hatfield; R Gill; C Brazell
Journal:  Eur J Pharmacol       Date:  1992-05-27       Impact factor: 4.432

6.  Endogenous adenosine inhibits hippocampal CA1 neurones: further evidence from extra- and intracellular recording.

Authors:  H L Haas; R W Greene
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

7.  Brain adenosine production in the rat during 60 seconds of ischemia.

Authors:  H R Winn; R Rubio; R M Berne
Journal:  Circ Res       Date:  1979-10       Impact factor: 17.367

8.  Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis.

Authors:  K A Haberny; S Pou; C U Eccles
Journal:  Neurosci Lett       Date:  1992-11-09       Impact factor: 3.046

9.  Increases in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia.

Authors:  J W Phillis; G A Walter; M H O'Regan; R E Stair
Journal:  J Cereb Blood Flow Metab       Date:  1987-12       Impact factor: 6.200

10.  The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats.

Authors:  W Löscher; R Annies; D Hönack
Journal:  Neurosci Lett       Date:  1991-07-22       Impact factor: 3.046

View more
  1 in total

1.  Neuropeptide Y and somatostatin immunoreactivity in the rat hippocampus after moderate hypoxia.

Authors:  C Schwarzer; G Sperk; C Rauca; W Pohle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.